EGFR, IL6, SRC, ESR1, MTOR, MAPK3, PTGS2, MAPK1, and ABCB1 are crucial components of this network and have been identified as significant targets for treating cancer with the A. ostoyae mycelium ethanol extract (AOME). This evidence concerns the gene SRC and cancer.